PSA 4 or lower ng/mL

The National Cancer Institute is direct about what this band is not: "There is no single threshold that distinguishes a normal versus an abnormal PSA result." A result at or under 4.0 ng/mL is the range that has traditionally not triggered a biopsy, and NCI adds that "the higher someone's PSA level, the likelier it is that prostate cancer is present." So the number inside this band carries information of its own, and the guideline bodies now use it to set how often you are tested rather than to declare you clear.

How the AUA uses a low PSA. The 2026 AUA/SUO guideline offers a baseline PSA between ages 45 and 50 (Statement 4, Conditional, Grade B), and from 40 to 45 for people at increased risk: Black race, germline mutations, or a strong family history (Statement 5, Strong, Grade B). Between 50 and 69 it recommends screening every 2 to 4 years (Statement 6, Strong, Grade A), and Statement 7 lets clinicians stretch or shorten that by PSA level. The guideline's discussion puts numbers on it: an interval of 1 to 4 years for a PSA of 1 to 3 ng/mL between ages 45 and 70, and a longer one for a PSA under 1 or below the age-specific median. Median PSA in the 40s runs about 0.4 to 0.7 ng/mL and in the 50s about 0.7 to 1.0. At age 60 with a PSA under 1, the 25-year risk of metastasis in an unscreened Swedish cohort was 0.5 percent and of death 0.2 percent, which the guideline says makes it reasonable to lengthen the interval substantially or stop, absent other risk factors. At 75 or older with a PSA under 3, the discussion says clinicians may discontinue or substantially lengthen the interval.

Where the bodies part. The USPSTF's 2018 statement gives a Grade C to screening at 55 to 69 (an individual decision after discussing benefits and harms) and a Grade D against screening at 70 and older. It found "inadequate evidence that screening younger men or performing baseline PSA-based screening provides benefit," which is the AUA's Statement 4 in reverse. USPSTF has had this topic under update since a final research plan dated December 21, 2023, with no draft recommendation posted as of September 10, 2026.

Why 4.0 is the wrong line for most ages. The AUA guideline says the 4 ng/mL threshold "is too high for people in their 40s and 50s and too low for people in their 70s and 80s," and that most age-varying studies use 2.5 for the 40s, 3.5 for the 50s, 4.5 for the 60s and 6.5 for the 70s. Those figures trace to a 1993 study of 471 healthy men in one Minnesota county, enrolled in 1989 to 1991 and tested on the Tandem-R assay, reported as 95th percentiles, not as diagnostic cut points. No current body recommends them as a rule, and the AUA notes the risk of cancer in men with a PSA under 4 and an abnormal rectal exam was 3 percent in one US cohort. A low PSA lowers the odds. It does not close the question, and it does not replace the conversation Statement 1 requires.